Authors: VILLALONACALERO M EDER J TOPPMEYER D ALLEN L VELAGAPUDI R MYERS M AMATO A KAGENHALLET K RAZVILLAS B OCONNOR L FRAM R KUFE D VONHOFF D ROWINSKY E

Citation: M. Villalonacalero et al., PHASE-I AND PHARMACOKINETIC (PK) STUDY OF LU79553, A NOVEL BIS-NAPHTHALAMIDE ON A DAILY X 5 SCHEDULE, Annals of oncology, 9, 1998, pp. 249-249

Authors: RUBIN E ZAMEK R MEDINA M TOPPMEYER D BUBEN J PRIEST T JORDAN C SLAPAK C

Citation: E. Rubin et al., A PHASE-I DOSE-ESCALATING TRIAL OF LY335979, A POTENT MULTIDRUG-RESISTANCE MODULATOR, COMBINED WITH DOXORUBICIN IN PATIENTS WITH ADVANCED MALIGNANCIES, Annals of oncology, 9, 1998, pp. 553-553

Authors: VILLALONACALERO MA BAKER SD HAMMOND L AYLESWORTH C ECKHARDT SG KRAYNAK M FRAM R FISCHKOFF S VELAGAPUDI R TOPPMEYER D RAZVILLAS B JAKIMOWICZ K VANHOFF DD ROWINSKY E

Citation: Ma. Villalonacalero et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE WATER-SOLUBLE DOLASTATIN-15 ANALOG LU103793 IN PATIENTS WITH ADVANCED SOLID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2770-2779

Authors: RUBIN E WOOD V BHARTI A TRITES D LYNCH C HURWITZ S BARTEL S LEVY S ROSOWSKY A TOPPMEYER D KUFE D

Citation: E. Rubin et al., A PHASE-I AND PHARMACOKINETIC STUDY OF A NEW CAMPTOTHECIN DERIVATIVE,9-AMINOCAMPTOTHECIN, Clinical cancer research, 1(3), 1995, pp. 269-276

Authors: RUBIN E PANTAZIS P BHARTI A TOPPMEYER D GIOVANELLA B KUFE D

Citation: E. Rubin et al., IDENTIFICATION OF A MUTANT HUMAN TOPOISOMERASE-I WITH INTACT CATALYTIC ACTIVITY AND RESISTANCE TO 9-NITRO-CAMPTOTHECIN, The Journal of biological chemistry, 269(4), 1994, pp. 2433-2439